Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus

2001 ◽  
Vol 10 (3) ◽  
pp. 439-454 ◽  
Author(s):  
Judith L Treadway ◽  
Phil Mendys ◽  
Dennis J Hoover
2015 ◽  
Vol 18 (1) ◽  
pp. 101-109 ◽  
Author(s):  
Ivan Nikolaevich Tyurenkov ◽  
Denis Vladimirovich Kurkin ◽  
Elena Vladimirovna Volotova ◽  
Dmitriy Alexandrovich Bakulin ◽  
Elena Michailovna Lomkina

In this review we discuss ten promising biological targets of interest for treating type 2 diabetes mellitus, obesity and metabolic syndrome. Namely, we address current experimental and clinical data on several new compounds that affect SGLT2, 11b-HSD1, PTP1B, SCD1, Il-1?. , fructose-1,6-bisphosphatase, glycogen phosphorylase, SIRT1, DGAT-1 and GPR119. The body of data shows potential of these substances to become effective antidiabetic agents.


2015 ◽  
Vol 21 ◽  
pp. 280-281
Author(s):  
Medha Munshi ◽  
Jasvinder Gill ◽  
Jason Chao ◽  
Elena Nikonova ◽  
Andreas Stuhr ◽  
...  

2015 ◽  
Vol 21 ◽  
pp. 106
Author(s):  
Franco Grimaldi ◽  
Laura Tonutti ◽  
Claudia Cipri ◽  
Cecilia Motta ◽  
Maria Antonietta Pellegrini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document